These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

632 related items for PubMed ID: 9229690

  • 1. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R, Borota J, Belić A, Gebauer E, Stefanović N.
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [Abstract] [Full Text] [Related]

  • 2. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C, Coleman DL.
    Schweiz Med Wochenschr; 1991 Mar 23; 121(12):397-412. PubMed ID: 1709294
    [Abstract] [Full Text] [Related]

  • 3. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T.
    Klin Padiatr; 2001 Mar 23; 213(4):212-38. PubMed ID: 11528556
    [Abstract] [Full Text] [Related]

  • 4. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001 Mar 23; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 5. [Myeloid hemopoietic growth factors. Therapeutic possibilities and clinical experiences].
    Hansen B, Johnsen HE.
    Ugeskr Laeger; 1990 Oct 29; 152(44):3232-7. PubMed ID: 1700524
    [Abstract] [Full Text] [Related]

  • 6. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar 29; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 7. The promise of colony-stimulating factors in clinical practice.
    Glaspy JA, Ambersley JM.
    Oncol Nurs Forum; 1990 Mar 29; 17(1 Suppl):20-4. PubMed ID: 1689043
    [Abstract] [Full Text] [Related]

  • 8. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 29; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 9. Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs.
    Mishu L, Callahan G, Allebban Z, Maddux JM, Boone TC, Souza LM, Lothrop CD.
    J Am Vet Med Assoc; 1992 Jun 15; 200(12):1957-64. PubMed ID: 1379221
    [Abstract] [Full Text] [Related]

  • 10. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
    Meng FY, Xu B, Sun J, Yang Y, Niu JN.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep 15; 24(9):1051-2. PubMed ID: 15447861
    [Abstract] [Full Text] [Related]

  • 11. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
    Motoyoshi K.
    Nihon Rinsho; 1992 Aug 15; 50(8):1967-72. PubMed ID: 1279240
    [Abstract] [Full Text] [Related]

  • 12. [Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Gratwohl A, Dazzi H, Tichelli A, Stebler C, Wernli M, Thomssen C, Kim I, Dieterle A, Obrist R, Stern A.
    Schweiz Med Wochenschr; 1991 Mar 23; 121(12):413-7. PubMed ID: 2028244
    [Abstract] [Full Text] [Related]

  • 13. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M, Ganser A.
    Ther Umsch; 1996 Nov 23; 53(11):863-73. PubMed ID: 8984692
    [Abstract] [Full Text] [Related]

  • 14. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Nov 23; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 15. The clinical benefits of recombinant human granulocyte colony stimulating factor in the treatment of cancer patients.
    Bacigalupo A.
    Eur J Cancer; 1994 Nov 23; 30A Suppl 3():S26-9. PubMed ID: 7535069
    [Abstract] [Full Text] [Related]

  • 16. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
    Avigan D, Wu Z, Gong J, Joyce R, Levine J, Elias A, Richardson P, Milano J, Kennedy L, Anderson K, Kufe D.
    Clin Cancer Res; 1999 Oct 23; 5(10):2735-41. PubMed ID: 10537336
    [Abstract] [Full Text] [Related]

  • 17. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
    Barge AJ.
    Bone Marrow Transplant; 1993 Oct 23; 11 Suppl 2():1-11. PubMed ID: 8334433
    [Abstract] [Full Text] [Related]

  • 18. [Application of CSF to cancer treatment].
    Takaku F.
    Gan To Kagaku Ryoho; 1988 Apr 23; 15(4 Pt 2-1):739-46. PubMed ID: 2455478
    [Abstract] [Full Text] [Related]

  • 19. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A, Donohue M, Liu L, Medina B, Corringham S, Ihasz A, Carrier E, Castro JE, Holman PR, Xu R, Law P, Ball ED, Lane TA.
    Transfusion; 2007 Nov 23; 47(11):2153-60. PubMed ID: 17958545
    [Abstract] [Full Text] [Related]

  • 20. Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function.
    Tkatch LS, Tweardy DJ.
    Lymphokine Cytokine Res; 1993 Dec 23; 12(6):477-88. PubMed ID: 7510132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.